New Targets to Treat Type 1 Diabetes

Chemist Arturo Vegas wins $1.4 million NIH grant to develop therapies that intervene at early stage of disease Arturo Vegas wants to create novel therapies that will either suppress rogue immune cells attacking the pancreas of people with type 1 diabetes or strengthen the pancreas’ defenses against the rogue cells. Photo courtesy of Arturo Vegas. […]

Tagged: , , , , , , , , , , , , , ,